Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Marc A. Cohen
Age : 56
Public asset : 91,633,932 USD
Linked companies : C4 Therapeutics, Inc. - Frequency Therapeutics, Inc.
Summary 
Mr. Marc A. Cohen is an Executive Chairman at Raqia Therapeutics, Inc., an Executive Chairman at Regenacy Pharmaceuticals LLC, a Chairman at Frequency Therapeutics, Inc., an Executive Chairman at Mana Therapeutics, Inc., an Executive Chairman at C4 Therapeutics, Inc., a Co-Founder & CEO at Cobro Ventures, Inc., a Chairman & Co-Chief Executive Officer at Bublup, Inc., an Executive Chairman at OncoPep, Inc., an Executive Chairman & Chief Executive Officerc at Nextrna Therapeutics and a President & Chief Executive Officer at Opnet Analysis, Inc.

He is on the Board of Directors at Dana-Farber Cancer Institute, Inc. Mr. Cohen was previously employed as a Chairman, Secretary & Treasurer by Acetylon Pharmaceuticals, Inc., a Chief Financial Officer & Vice President by PharmAthene, Inc., a Chief Financial Officer, Secretary & Treasurer by Air Cargo, Inc., a Chief Financial Officer & Treasurer by OTG Software, Inc., a Chief Financial Officer by Trusted Information Systems, Inc., a Chairman, Chief Executive Officer & Secretary by OPNET Technologies, Inc., and a Consultant by Booz Allen Hamilton, Inc.

He received his undergraduate degree from Harvard University and a graduate degree from Stanford University.


Current positions of Marc A. Cohen 
NameTitle Since
C4 Therapeutics, Inc.
(Biotechnology & Medical Research)
Executive Chairman 2020
Frequency Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2020
Opnet Analysis, Inc. President & Chief Executive Officer -
Cobro Ventures, Inc. Co-Founder & CEO 2012
Bublup, Inc. Co-Chief Executive Officer 2012
Nextrna Therapeutics Executive Chairman & Chief Executive Officer -
Regenacy Pharmaceuticals LLC Executive Chairman 2016
Mana Therapeutics, Inc. Executive Chairman 2018
Raqia Therapeutics, Inc. Executive Chairman 2020
OncoPep, Inc. Executive Chairman -
Dana-Farber Cancer Institute, Inc. Trustee -


Holdings of Marc A. Cohen 
NameEquities%Valuation
C4 Therapeutics, Inc. (CCCC)
(Biotechnology & Medical Research)
1,974,7244.08%87,717,240 USD
Frequency Therapeutics, Inc. (FREQ)
(Biotechnology & Medical Research)
623,6771.82%3,916,692 USD


Marc A. Cohen: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
11/17HENRIK FISKER : Fisker unveils electric SUVs to beat Tesla over driving range
RE
11/16ELON MUSK : Tesla's Musk sells another 934,000 shares to pay taxes after exercising options - filing
RE
11/16TED ROGERS : Rogers names Staffieri interim CEO as chair stamps authority after family feud
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
11/22MUKESH AMBANI : India's salesmen face ruin as tycoon Ambani targets mom-and-pop stores
RE
11/29ANIL AMBANI : India central bank to start bankruptcy procedure against Reliance Capital; co to comply
RE
More news


© 2021 People and Ownership :   
Marc A. Cohen : Connections